SPY336.84+0.01 0.00%
DIA279.80+0.38 0.14%
IXIC11,019.30-23.20 -0.21%

Spring Bank Pharmaceuticals shares are trading higher after the company announced it has agreed to combine with F-star Therapeutics to pursue the mission of 'creating the next-generation immunotherapies. UPDATE: Shares have since reversed.

Benzinga · -